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1. Introduction 
Cyclic adenosine 3’,5’-monophosphate (cyclic AMP) 
is postulated as an intracellular mediater for the con- 
trol of several enzymes forming systems [ 1,2] . Induc- 
tion of rat liver tyrosine aminotransferase (L-tyrosine: 
2-oxoglutarate aminotransferase, EC 2.6.1.5) by glu- 
cagon [3], epinephrine [4] and cyclic AMP [4, 5] has 
been shown in adrenalectomized animals, in perfused 
liver and in fetal liver. E.pinephrine induced increase 
of the enzyme activity in fetal liver is blocked by 
dichloroisoproterenol, an adrenergic blocking agent 
[41 . 
Phentolamine (2-[N-(m-hydroxyphenyl)-p-toluidino- 
methyl] imidazole), an adrenergic blocking agent, 
is reported to be an inducer of liver tyrosine amino- 
transferase in intact rats, but the induction by this 
agent is completely abolished by either adrenalectomy 
or hypophysectomy [6] . 
During a study of the control mechanism of liver 
tyrosine aminotransferase, in viva, by non-hormonal 
substances, it was found that phentolamine selec- 
tively blocked the benzoate or tryptophan mediated 
induction of this enzyme. These results are presented 
in this report. 
2. Experimental 
Adrenalectomized male Wister rats of 130 to 170 g 
body weight were fasted overnight before the experi- 
ments began. They were given 0.9% NaCl as drinking 
water at all times. Sodium benzoate, hydrocortisone 
succinate (Solu-Cortef, Upjohn) or glucagon (Novo) 
was injected intraperitoneally. L-Tryptophan was ad- 
ministered in 2 ml of 0.9% NaCl by stomach tube. Rats 
were killed between 1 to 3 p.m. Tyrosine aminotrans- 
ferase was assayed with liver homogenate according to 
the method of Kenney [7] with modifications. p-Hy- 
droxyphenylpyruvate formed was determined by a mo- 
dification of the Briggs method [8]. Tryptophan 
pyrrolase (L-tryptophan:oxygen oxidoreductase, 
EC 1.13.1.12) was assayed with the 6000 g supernatant 
fraction of liver homogenate according to the method 
of Feigelson and Greengard [9]. Protein concentrations 
were determined by the biuret procedure. 
3. Results 
Administration of sodium benzoate to adrenalelecto- 
mized rats results in a several fold increase in the acti- 
vity of liver tyrosine aminotransferase by a process 
sensitive to puromycin and actinomycin D [lo] . As 
seen in table 1 and fig. 1, the induction of tyrosine 
aminotransferase by benzoate was repressed by the 
administration of phentolamine. Phentolamine alone 
did not change the basal level of the enzyme in adrenal- 
ectomized rats, as previously reported by Govier and 
Lovenberg [6]. The addition of phentolamine to the 
assay system up to 3 X lo4 M showed no effect on the 
enzyme activity. Among the several adrenergic blocking 
agents tested, phenoxybenzamine (dibenzylline) repres- 
sed the induction as effectively as phentolamine, but 
ergotamine and propranolol showed no effect. 
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Table 1 
Effect of phentolamine on the induction of tyrosine aminotransferase in adrenalectomized rats. 
July 1970 
Treatment 
Period of No. of TAT activity TP activity 
induction (hr) animals (m~moles/min/mg) (mpmoles/hr/mg) 
None 14 16.9 * 2.8 
Phentolamine (3 mg) 3 7 14.1 + 2.0 
Benzoate (30 mg) 3 6 50.7 f 3.1 
Benzoate + phentolamine (3 mg) 3 4 23.3 f 3.5 
Benzoate + phenoxybenzamine (2 mg) 3 4 21.1+ 2.0 
Benzoate + ergotamine (1 mg) 2 2 42.0 
Benzoate + propranolol(1 mg) 3 3 42.8 + 3.6 
None 4 19.0 f 3.7 26.3 f 5.1 
Phentolamine* (7 mg) 4 4 16.7 + 1.2 29.6 + 3.1 
Glucagon (0.5 mg) 3 3 40.4 f 3.9 
Glucagon + phentolamine* (5 mg) 3 4 39.8 ?r 4.2 
Hydrocortisone (10 mg) 4 5 114.4 f 10.0 161.3 +_ 21.3 
Hydrocortisone + phentolamine* (7 mg) 4 5 124.8? 3.0 135.5 f 13.3 
Tryptophan (100 mg) 4 5 64.2 f 8.2 91.2 + 107 
Tryptophan + phentolamine* (7 mg) 4 5 30.5 f 1.9 94.0 + 11.3 
The rats weighing 130 to 170 g were fasted overnight. The indicated doses of sodium benzoate, glucagon, hydrocortisone succinate 
or L-tryptophan were administered as described in Experimental, Phentolamine (Regitine, CIBA), ergotamine (Sigma), phenoxy- 
benzamine (dissolved in 50% ethanol) or propranolol (Inderal) was injected intraperitoneally. Tyrosine aminotransferase (TAT) 
activity is expressed as mmoles p-hydroxyphenylpyruvate formed/min/mg protein and tryptophan pyrrolase (TP) activity, as 
mpmoles kynurenine formed/hr/mg protein. Each value is the average ? standard deviation of the mean. 
* Phentolamine was given at 0 (3 mg), 1.5 (2 mg) and 3 hr (2 mg) after the inducer. 
It might be argued that phentolamine or phenoxy- 
benzamine depresses the synthesis of all proteins in 
the liver to an equal degree, and that the repressive 
effect of these agents is seen on another inducing 
processes of liver enzymes. To examine this possibility, 
the effect of phentolamine on the induction of tyrosine 
aminotransferase and tryptophan pyrrolase by other 
inducers was tested. As shown in table 1, induction of 
these enzymes by glucagon or hydrocortisone was not 
affected even by the repeated administration of phentol- 
amine. However, induction of tyrosine aminotransferase 
by tryptophan [ 1 l] was repressed under the condi- 
tion in which the induction of tryptophan pyrrolase 
was not affected. 
These results indicate that the repressive effect of 
phentolamine is selective and does not result from the 
depression of the general protein synthesizing process 
in the liver nor from the disturbance of the absorption 
or circulation of the inducer. 
4. Discussion 
Although the increased activity of tyrosine amino- 
transferase appears to result from the de now syn- 
thesis of enzyme protein, it is not clear whether the 
administered benzoate or tryptophan acts directly on 
the liver or stimulates the secretion of some hormone 
which brings about the induction of this enzyme in 
the liver. However, present results indicate that en- 
zyme induction by benzoate or tryptophan is selec- 
tively repressed by phentolamine. 
It is proposed that the adrenergic blocking agents 
block the physiological responses of hormones by 
inhibiting the hormone mediated accumulation of 
cyclic AMP [12-141. From this concept and the 
present results, it is suggested that the mechanism of 
benzoate or tryptophan mediated induction of tyros- 
ine aminotransferase includes a cyclic AMP accumulat- 
ing process, which is sensitive to phentolamine and 
317 
Volume 8, number 6 FEBS LETTERS July 1970 
10 
1 o-e- 
0 1 2 3 4 5 6 7 
TIME (HR) 
Fig. 1. Time course of induction of tyrosine aminotransferase 
by benzoate and its repression by phentolamine in adrenalecto- 
mired rats. The rats were given the following treatment (intra- 
peritoneal injection): 
o---o, sodium benzoate (130 mg/lSO g body weight) 
o---q sodium benaoate + phentolamine (3 mg/lSO g body 
weight) 
-, sodium benaoate + phentohunine (3, 2 and 2 mg at 0, 
1.5 and 3 hr, respectively) 
l - - -0, sodium benzoate + phentolamine (3 mg at 1.5 or 3 hr 
after benzoate). 
Each point is the average of 4 to 7 animals. Vertical bars 
indicate standard deviation of the mean. 
phenoxybenzamine. However, it remains as a possible 
mechanism that phentolamine or phenoxybenzamine 
stimulates the release of some endogenous repressive 
substance, or forms a complex with the enzyme pro- 
tein or pyridoxal phosphate in viPo as suggested in the 
case of norepinephrine [ 151. 
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